Skip to main content
. Author manuscript; available in PMC: 2013 Jan 14.
Published in final edited form as: Medchemcomm. 2011 Oct 26;3:65–67. doi: 10.1039/C1MD00233C

Fig. 3. Competitive inhibition by butylacetylphosphonate (BAP).

Fig. 3

A) DXP synthase. The concentration of pyruvate was varied with increasing concentrations of BAP: 0 (○), 10 (●), 25 (□), and 50 (■) μM BAP. B) E1 subunit of pyruvate dehydrogenase. The concentration of pyruvate was varied at with increasing concentrations of BAP: 0 (○), 0.2 (●), 0.5 (□), and 1.0 (■) mM BAP.